Ionis Pharmaceuticals (IONS) Capital Expenditures Growth (5y) (2014 - 2026)
Ionis Pharmaceuticals (IONS) Capital Expenditures Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - |
| 10 | Ionis Pharmaceuticals | 9.37 Bn | 7.45 Bn | 243.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.14% |
| Dec 31, 2025 | -50.66% |
| Sep 30, 2025 | -14.88% |
| Jun 30, 2025 | -6.56% |
| Mar 31, 2025 | 69.31% |
| Dec 31, 2024 | 26.85% |
| Sep 30, 2024 | -10.65% |
| Jun 30, 2024 | 9.20% |
| Mar 31, 2024 | 6.83% |
| Dec 31, 2023 | -27.19% |
| Sep 30, 2023 | 19.11% |
| Jun 30, 2023 | 12.61% |
| Mar 31, 2023 | 34.91% |
| Sep 30, 2022 | 20.93% |
| Jun 30, 2022 | -11.71% |
| Mar 31, 2022 | -3.53% |
| Dec 31, 2021 | 20.87% |
| Sep 30, 2021 | 25.91% |
| Jun 30, 2021 | 10.59% |
| Mar 31, 2021 | 23.06% |